Allergen‐loaded biodegradable poly(d,l‐lactic‐co‐glycolic) acid nanoparticles down‐regulate an ongoing Th2 response in the BALB/c mouse model

TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties

Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692 · see citing works

Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper

Bousquet, J., Lockey, R. F., & Malling, H. ‐. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,582 · see citing works

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

Noon, L. (1911) · The Lancet · doi:10.1016/s0140-6736(00)78276-6 · Cited by 1,343 · see citing works

Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.

Aalberse, R. C., van der Gaag, R., & van Leeuwen, J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.722 · Cited by 740 · see citing works

Adjuvants — a balance between toxicity and adjuvanticity

Rk, G., Relyveld, E. H., Lindblad, E. B., Bizzini, B., Ben‐Efraim, S., & Gupta, C. K. (1993) · Vaccine · doi:10.1016/0264-410x(93)90190-9 · Cited by 546 · see citing works

Aluminium Hydroxide Adjuvant Initiates Strong Antigen-Specific Th2 Responses in the Absence of IL-4- or IL-13-Mediated Signaling

Brewer, J. M., Conacher, M., Hunter, C. A., Mohrs, M., Brombacher, F., & Alexander, J. K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6448 · Cited by 442 · see citing works

The Role of IL-10 and TGF-β in the Differentiation and Effector Function of T Regulatory Cells

Levings, M. K., Bacchetta, R., Schulz, U., & Roncarolo, M. G. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000067596 · Cited by 423 · see citing works

Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay

Carson, R. T., & Vignali, D. A. A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00069-1 · Cited by 404 · see citing works

Poly(?-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration

Jones, D. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00266-6 · Cited by 253 · see citing works

IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa *

JAROLIM, E., Rumpold, H., ENDLER, A. T., Ebner, H., Breitenbach, M., Scheiner, O., & Kraft, D. (1989) · Allergy · doi:10.1111/j.1398-9995.1989.tb04169.x · Cited by 218 · see citing works

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells

Moore, A. (1995) · Vaccine · doi:10.1016/0264-410x(95)00184-3 · Cited by 165 · see citing works

Controlled release microparticles for vaccine development

O’Hagan, D. T., Jeffery, H., Roberts, M. J. J., McGee, J. P., & Davis, S. S. (1991) · Vaccine · doi:10.1016/0264-410x(91)90295-h · Cited by 149 · see citing works

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

Ball, T., Sperr, W. R., Valent, P., Lidholm, J., Spitzauer, S., Ebner, C., Kraft, D., & Valenta, R. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06 · Cited by 141 · see citing works

Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants

Raghuvanshi, R. S., Katare, Y. K., Lalwani, K., Ali, M. M., Singh, O., & Panda, A. K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00342-3 · Cited by 140 · see citing works

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity

Nixon, D. F., Hioe, C. E., Chen, P., Bian, Z., Kuebler, P., Li, M.-L., Qiu, H., Li, X.-M., Singh, M., Richardson, J. L., et al. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00099-0 · Cited by 133 · see citing works

Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres

Igartúa, M., Hernández, R. M., Esquisabel, A., Rodríguez‐Gascón, A., Calvo, M. B., & Pedraz, J. L. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00077-7 · Cited by 105 · see citing works

Comparison of Poly(dl-Lactide-co-glycolide) and Polystyrene Microsphere Targeting to Intestinal M Cells

Jepson, M. A., Simmons, N. L., O’Hagan, D. T., & Hirst, B. H. (2003) · Journal of drug targeting · doi:10.1080/10611860310001636502 · Cited by 101 · see citing works

Encapsulation and stabilization of nerve growth factor into poly(lactic‐co‐glycolic) acid microspheres

Lam, X. M., Duenas, E. T., & Cleland, J. L. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1088 · Cited by 100 · see citing works

Monoclonal Antibodies against Birch Pollen Allergens: Characterization by Immunoblotting and Use for Single-Step Affinity Purification of the Major Allergen Bet v I

Jensen‐Jarolim, E., Tejkl, M., Rohac, M., Schlerka, G., Scheiner, O., Kraft, D., Breitenbach, M., & Rumpold, H. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235000 · Cited by 96 · see citing works

Encephalitogenic T?cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvesselsin vivo

Laschinger, M., Vajkoczy, P., & Engelhardt, B. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200212)32:12 · Cited by 82 · see citing works

Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66

Rosas, J. E., Hernández, R. M., Rodríguez‐Gascón, A., Igartúa, M., Guzmán, F., Patarroyo, M. E., & Pedraz, J. L. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00192-x · Cited by 67 · see citing works

Biodegradable microspheres containing influenza A vaccine: immune response in mice

Hilbert, A. K., Fritzsche, U., & Kissel, T. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00323-5 · Cited by 67 · see citing works

Poly-DL-lactide-co-glycolide microspheres as a controlled release antigen delivery system

Lima, K. M., & Júnior, J. M. R. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000200005 · Cited by 65 · see citing works

Allergen mimotopes in food enhance type I allergic reactions in mice

Jensen‐Jarolim, E., Wiedermann, U., Ganglberger, E., Zürcher, A. W., Stadler, B. M., Boltz‐Nitulescu, G., Scheiner, O., & Breiteneder, H. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.12.1586 · Cited by 64 · see citing works

A long-term follow-up study of hyposensitization with immunoblotting

Jensen‐Jarolim, E., Poulsen, L. K., Stadler, B. M., Mosbech, H., ØSterballe, O., Kraft, D., & Weeke, B. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(90)90043-4 · Cited by 62 · see citing works

Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers

Venkataprasad, N. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00372-7 · Cited by 55 · see citing works

Mechanisms of adjuvancy: I?metal oxides as adjuvants

Naim, J. O. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00016-9 · Cited by 54 · see citing works

Intranasal Treatment with a Recombinant Hypoallergenic Derivative of the Major Birch Pollen Allergen Bet v 1 Prevents Allergic Sensitization and Airway Inflammation in Mice

Wiedermann, U., Herz, U., Baier, K., Vrtala, S., Neuhaus‐Steinmetz, U., Bohle, B., Dekan, G., Renz, H. E., Ebner, C., Valenta, R., et al. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000049496 · Cited by 51 · see citing works

Resorbable polymeric microspheres for drug delivery — production and simultaneous surface modification using PEO-PPO surfactants

Coombes, A. G. A., Scholes, P., Davies, M. C., Illum, L., & Davis, S. S. (1994) · Biomaterials · doi:10.1016/0142-9612(94)90165-1 · Cited by 50 · see citing works

Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres

Sturesson, C., Artursson, P., Ghaderi, R., Johansen, K., Mirazimi, A., Uhnoo, I., Svensson, L., Albertsson, A., & Carlfors, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00014-0 · Cited by 45 · see citing works

Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice

Chattaraj, S. C., Rathinavelu, A., & DAS, S. K. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00161-8 · Cited by 40 · see citing works

Preparation of 2,6-Dimethyl-4-arylpyridine- 3,5-dicarbonitrile: A Paired Electrosynthesis

Batanero, B., Barba, F., & Martı́n, A. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo016065h · Cited by 39 · see citing works

Biodegradable Microparticles with Different Release Profiles: Effect on the Immune Response After a Single Administration via Intranasal and Intramuscular Routes

Spiers, I. D., Eyles, J. E., Baillie, L. W. J., Williamson, E. D., & Alpar, H. O. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001777324 · Cited by 37 · see citing works

Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae

Jones, D. (1995) · Vaccine · doi:10.1016/0264-410x(95)99876-j · Cited by 36 · see citing works

Tetanus toxoid loaded ‘preformed microspheres’ of cross-linked dextran

Diwan, M., Khar, R. K., & Talwar, G. P. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00140-2 · Cited by 28 · see citing works

The Immune Response to Intrinsic and Extrinsic Allergens: Determinants of Allergic Disease

Woodfolk, J. A., & Platts‐Mills, T. A. E. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000067595 · Cited by 24 · see citing works

A new synthetic absorbable suture.

Postlethwait, R. W., & Smith, B. M. (1975) · PubMed · Cited by 20 · see citing works

ALLERGEN IMMUNOTHERAPY

Tippett, J. (1999) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(05)70058-8 · Cited by 16 · see citing works

Quantitative Assessment of Immediate Cutaneous Hypersensitivity in a Model of Genetic Predisposition to Atopy

Daser, A., Bätjer, N., Kölsch, U., Kötz, K., Schmeling, H., Schou, C., & Harald, R. (1998) · International Archives of Allergy and Immunology · doi:10.1159/000024017 · Cited by 13 · see citing works

Prolonged Immune Response Evoked by a Single Subcutaneous Injection of Microcapsules Having a Monophasic Antigen Release

Sah, H., & Chien, Y. W. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05872.x · Cited by 12 · see citing works

Preliminary Assessment of the Immune Response to<i>Olea europaea</i>Pollen Extracts Encapsulated into PLGA Microspheres

Igartua, M., Hernández, R. M., Gutierro, I., Gascón, A. R., & Pedraz, J. L. (2001) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120000299 · Cited by 12 · see citing works

Corticotropin releasing hormone (CRH) increases beta-endorphin (beta-end like) concentration in cerebrospinal fluid of rats with vasospasm following subarachnoid hemorrhage.

Henryk, S., Jośko, J., Jędrzejowska–Szypułka, H., Jarząb, B., & Döhler, K.-D. (1999) · PubMed · Cited by 11 · see citing works

Correlation Between In Vitro Release and In Vivo Immune Response from Biodegradable Polymer Particles Entrapping Tetanus Toxoid

Raghuvanshi, R. S., Singh, O., & Panda, A. K. (2002) · Drug Delivery · doi:10.1080/10426500290095557 · Cited by 11 · see citing works

Quantitative Evaluation of Passive Cutaneous Anaphylaxis (PCA) Using a Hand-Held Spectrophotometer.

Akiyama, H., Teshima, R., Akasaka, R., FUJIMORI, K., Goda, Y., Sawada, J., & TOYODA, M. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.1112 · Cited by 9 · see citing works

New Synthetic Absorbable Suture

Hudson, H. C., & Glenn, J. F. (1979) · The Journal of Urology · doi:10.1016/s0022-5347(17)56451-4 · Cited by 9 · see citing works

Minireview: Nanoparticles and the Immune System

Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914 · see citing works

Biocompatibility of engineered nanoparticles for drug delivery

Naahidi, S., Jafari, M., Edalat, F., Raymond, K. P., Khademhosseini, A., & Chen, P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.013 · Cited by 814 · see citing works

Synthesis and characterization of PLGA nanoparticles

Astete, C. E., & Sabliov, C. M. (2006) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856206775997322 · Cited by 782 · see citing works

Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells

Palomares, Ó., Akdis, M., Martín‐Fontecha, M., & Akdiş, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12555 · Cited by 336 · see citing works

Current understanding of interactions between nanoparticles and the immune system

Dobrovolskaia, M. A., Shurin, M. R., & Shvedova, A. A. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.022 · Cited by 313 · see citing works

The ABC of clinical and experimental adjuvants—A brief overview

Brunner, R., Jensen‐Jarolim, E., & Pali‐Schöll, I. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.10.005 · Cited by 140 · see citing works

Cell Delivery of Therapeutic Nanoparticles

McMillan, J., Batrakova, E. V., & Gendelman, H. E. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-416020-0.00014-0 · Cited by 137 · see citing works

Polymeric nanogels as vaccine delivery systems

Ferreira, S. A., Gama, M., & Vilanova, M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.06.001 · Cited by 131 · see citing works

In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance

Pearson, R. M., Casey, L. M., Hughes, K. R., Miller, S. D., & Shea, L. D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.005 · Cited by 113 · see citing works

The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen

Bennewitz, N. L., & Babensee, J. E. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.08.023 · Cited by 101 · see citing works

Biomedical nanoparticles modulate specific CD4⁺T cell stimulation by inhibition of antigen processing in dendritic cells

Blank, F., Gerber, P., Rothen-Rutishauser, B., Sakulkhu, U., Salaklang, J., De Peyer, K., Gehr, P., Nicod, L. P., Hofmann, H., Geiser, T., et al. (2011) · Nanotoxicology · doi:10.3109/17435390.2010.541293 · Cited by 97 · see citing works

Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization

Smarr, C. B., Yap, W. T., Neef, T., Pearson, R. M., Hunter, Z. N., Ifergan, I., Getts, D. R., Bryce, P. J., Shea, L. D., & Miller, S. D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505782113 · Cited by 94 · see citing works

Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy

Rebouças, J. D. S., Esparza, I., Ferrer, M., Sanz, M. L., Irache, J. M., & Gamazo, C. (2012) · BioMed Research International · doi:10.1155/2012/474605 · Cited by 89 · see citing works

Recent advances in the use of nanoparticles for allergen‐specific immunotherapy

Pohlit, H., Bellinghausen, I., Frey, H., & Saloga, J. (2017) · Allergy · doi:10.1111/all.13199 · Cited by 84 · see citing works

Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy

Broos, S., Lundberg, K., Akagi, T., Kadowaki, K., Akashi, M., Greiff, L., Borrebaeck, C. A. K., & Lindstedt, M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.004 · Cited by 72 · see citing works

Adjuvants for immunotherapy

Pfaar, O., Cazan, D., Klimek, L., Larenas‐Linnemann, D. E., & Calderón, M. A. (2012) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32835a11d6 · Cited by 61 · see citing works

Adjuvants for allergy vaccines

Moingeon, P. E. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21688 · Cited by 61 · see citing works

Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice

Pali‐Schöll, I., Szöllösi, H., Starkl, P. M., Scheicher, B., Stremnitzer, C., Hofmeister, A., Roth‐Walter, F., Lukschal, A., Diesner, S. C., Zimmer, A., et al. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.03.003 · Cited by 60 · see citing works

Clinical use of adjuvants in allergen-immunotherapy

Klimek, L., Schmidt‐Weber, C. B., Kramer, M. F., Skinner, M. A., & Heath, M. D. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1292133 · Cited by 60 · see citing works

M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy

Roth-Walter, F., Schöll, I., Untersmayr, E., Fuchs, R., Boltz-Nitulescu, G., Weissenböck, A., Scheiner, O., Gabor, F., & Jensen-Jarolim, E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.010 · Cited by 58 · see citing works

Development of a Poly (lactic-co-glycolic acid) Particle Vaccine to Protect Against House Dust Mite Induced Allergy

Joshi, V. B., Adamcakova‐Dodd, A., Jing, X., Wongrakpanich, A., Gibson-Corley, K. N., Thorne, P. S., & Salem, A. K. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9624-5 · Cited by 57 · see citing works

Antacids and dietary supplements with an influence on the gastric pH increase the risk for food sensitization

Pali‐Schöll, I., Herzog, R., Wallmann, J., Szalai, K., Brunner, R., Lukschal, A., Karagiannis, P., Diesner, S. C., & Jensen‐Jarolim, E. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03468.x · Cited by 56 · see citing works

Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin

Roth-Walter, F., Schöll, I., Untersmayr, E., Ellinger, A., Boltz-Nitulescu, G., Scheiner, O., Gabor, F., & Jensen-Jarolim, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.052 · Cited by 55 · see citing works

Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma

Mei, L., Zeng, X., Liu, Z., Zhang, X., Ma, L., Xiao, X., Liu, X., & Yu, H. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51633 · Cited by 53 · see citing works

Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy

Schöll, I., Boltz-Nitulescu, G., & Jensen-Jarolim, E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.020 · Cited by 51 · see citing works

Are nanomaterials a threat to the immune system?

Dwivedi, P. D., Misra, A., Shanker, R., & Das, M. (2009) · Nanotoxicology · doi:10.1080/17435390802604276 · Cited by 51 · see citing works

Affinity determinations of purified IgE and IgG antibodies against the major pollen allergens Phl p 5a and Bet v 1a: Discrepancy between IgE and IgG binding strength

Hantusch, B., Pali‐Schöll, I., Harwanegg, C., Krieger, S., Becker, W., Spitzauer, S., Boltz‐Nitulescu, G., & Jensen‐Jarolim, E. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.10.002 · Cited by 48 · see citing works

Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy

Pandey, R. S., Sahu, S., Sudheesh, M. S., Madan, J., Kumar, M., & Dixit, V. K. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.02.004 · Cited by 47 · see citing works

Antigen-Specific Tolerance in Immunotherapy of Th2-Associated Allergic Diseases

Smarr, C. B., Bryce, P. J., & Miller, S. D. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013007046 · Cited by 47 · see citing works

Nanoparticle Based-immunotherapy Against Allergy

Gamazo, C., Gastaminza, G., Ferrer, M., Sanz, M. L., & Irache, J. M. (2014) · Immunotherapy · doi:10.2217/imt.14.63 · Cited by 46 · see citing works

Biodegradable pH-Sensitive Poly(ethylene glycol) Nanocarriers for Allergen Encapsulation and Controlled Release

Pohlit, H., Bellinghausen, I., Schömer, M., Heydenreich, B., Saloga, J., & Frey, H. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00458 · Cited by 44 · see citing works

Use of lectin-functionalized particles for oral immunotherapy

Diesner, S. C., Wang, X.-Y., Jensen-Jarolim, E., Untersmayr, E., & Gabor, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.146 · Cited by 40 · see citing works

Biodegradable PLGA Particles for Improved Systemic and Mucosal Treatment of Type I Allergy

Schöll, I., Kopp, T., Bohle, B., & Jensen-Jarolim, E. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.02.007 · Cited by 40 · see citing works

A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne

Gómez, S., Gamazo, C., Román, B. S., Grau, A., Espuelas, S., Ferrer, M., Sanz, M. L., & Irache, J. M. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.005 · Cited by 39 · see citing works

Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB/c mice

Salari, F., Varasteh, A., Vahedi, F., Hashemi, M., & Sankian, M. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.09.011 · Cited by 37 · see citing works

Intranasal vaccination with poly(lactide‐co‐glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization

Marazuela, E. G., Prado, N., Moro, E., Fernández‐García, H., Villalba, M., Rodrı́guez, R., & Batanero, E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02922.x · Cited by 37 · see citing works

Adjuvants and Vector Systems for Allergy Vaccines

Moingeon, P. E., Lombardi, V., Saint-Lu, N., Tourdot, S., Bodo, V., & Mascarell, L. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.03.001 · Cited by 34 · see citing works

Adjuvants for allergy immunotherapeutics

Gamazo, C., D’Amelio, C., Gastaminza, G., Ferrer, M., & Irache, J. M. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1348447 · Cited by 34 · see citing works

The Use of Adjuvants for Enhancing Allergen Immunotherapy Efficacy

Chesné, J., Schmidt‐Weber, C. B., & Bieren, J. E. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.009 · Cited by 33 · see citing works

Nanoparticle–allergen complexes for allergen immunotherapy

Felice, G. D., & Colombo, P. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s134630 · Cited by 33 · see citing works

Evaluation of size and dose effects of rChe a 3 allergen loaded PLGA nanoparticles on modulation of Th2 immune responses by sublingual immunotherapy in mouse model of rhinitis allergic

Hajavi, J., Hashemi, M., & Sankian, M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.03.040 · Cited by 30 · see citing works

Application of polymeric nanoparticles in immunotherapy

Craparo, E. F., & Bondı̀, M. L. (2012) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3283588c57 · Cited by 30 · see citing works

Development of a hollow mesoporous silica nanoparticles vaccine to protect against house dust mite induced allergic inflammation

Peng, X., Liang, Y., Yin, Y., Liao, H., & Li, L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.047 · Cited by 28 · see citing works

Co-Delivery of Ovalbumin and CpG Motifs into Microparticles Protected Sensitized Mice from Anaphylaxis

Román, B. S., Irache, J. M., Gómez, S., Gamazo, C., & Espuelas, S. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000189193 · Cited by 27 · see citing works

Development of poly(anhydride) nanoparticles loaded with peanut proteins: The influence of preparation method on the immunogenic properties

Rebouças, J. D. S., Irache, J. M., Camacho, A. I., Esparza, I., del Pozo, V., Sanz, M. L., Ferrer, M., & Gamazo, C. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.06.014 · Cited by 26 · see citing works

Induction of a Th1 immune response and suppression of IgE via immunotherapy with a recombinant hybrid molecule encapsulated in liposome–protamine–DNA nanoparticles in a model of experimental allergy

Nouri, H. R., Varasteh, A., Jaafari, M. R., Davies, J. M., & Sankian, M. (2015) · Immunologic Research · doi:10.1007/s12026-015-8659-8 · Cited by 24 · see citing works

Oral pretreatment with β-lactoglobulin derived peptide and CpG co-encapsulated in PLGA nanoparticles prior to sensitizations attenuates cow’s milk allergy development in mice

Liu, M., Thijssen, S., Hennink, W. E., Garssen, J., van Nostrum, C. F., & Willemsen, L. E. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1053107 · Cited by 24 · see citing works

Recombinant allergens for immunotherapy. Where do we stand?

Niederberger, V., & Valenta, R. (2004) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200412000-00013 · Cited by 23 · see citing works

Nanomedicine Faces Barriers

Debbage, P. L., & Thurner, G. C. (2010) · Pharmaceuticals · doi:10.3390/ph3113371 · Cited by 22 · see citing works

Role of nanostructures in allergy: Diagnostics, treatments and safety

Mayorga, C., Pérez‐Inestrosa, E., Rojo, J., Ferrer, M., & Montañez, M. I. (2021) · Allergy · doi:10.1111/all.14764 · Cited by 21 · see citing works

Nanomaterials in the Context of Type 2 Immune Responses—Fears and Potentials

Himly, M., Mills-Goodlet, R., Geppert, M., & Duschl, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00471 · Cited by 21 · see citing works

Potential of nanoparticles for allergen-specific immunotherapy – use of silica nanoparticles as vaccination platform

Scheiblhofer, S., Machado, Y. J., Feinle, A., Thalhamer, J., Hüsing, N., & Weiss, R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1203898 · Cited by 21 · see citing works

Genetic allergen modification in the development of novel approaches to specific immunotherapy

Mutschlechner, S., Deifl, S., & Bohle, B. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03317.x · Cited by 20 · see citing works

Pru p 3‐Glycodendropeptides Based on Mannoses Promote Changes in the Immunological Properties of Dendritic and T‐Cells from LTP‐Allergic Patients

Palomares, F., Ramos‐Soriano, J., Gómez, F., Mascaraque, A., Bogas, G., Perkins, J. R., González, M., Torres, M. J., Díaz‐Perales, A., Rojo, J., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900553 · Cited by 20 · see citing works

Intradermal immunization with ovalbumin‐loaded poly‐ɛ‐caprolactone microparticles conferred protection in ovalbumin‐sensitized allergic mice

Román, B. S., Espuelas, S., Gómez, S., Gamazo, C., Sanz, M. L., Ferrer, M., & Irache, J. M. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02654.x · Cited by 19 · see citing works

New and old adjuvants in allergen‐specific immunotherapy: With a focus on nanoparticles

Feng, Z., Yi, X., & Hajavi, J. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29941 · Cited by 17 · see citing works

Nanoparticles in allergen immunotherapy

Longo, A., Longo, V., & Colombo, P. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000782 · Cited by 15 · see citing works

Differences and similarities between sublingual immunotherapy of allergy and oral tolerance

Moingeon, P. E., & Mascarell, L. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.003 · Cited by 14 · see citing works

Turkish Guidelines for Diagnosis and Treatment of Allergic Rhinitis (ART)

Ecevit, M. C., Özcan, M., Can, İ. H., Tatar, E. Ç., Özer, S., Esen, E., Atan, D., Göde, S., Elsürer, Ç., Eryılmaz, A., et al. (2021) · Turkish Archives of Otorhinolaryngology · doi:10.4274/tao.2021.suppl.1 · Cited by 14 · see citing works

Preventive effects of "ovalbumin-conjugated celastrol-loaded nanomicelles'' in a mouse model of ovalbumin-induced allergic airway inflammation

Peng, X., Liang, Y., Li, J., 蔺丽慧, Wang, J., Yin, Y., Liao, H., & Li, L. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105172 · Cited by 12 · see citing works

Application of Nanoparticles for Immunotherapy of Allergic Rhinitis

Li, K., Jin, J., Yang, Y., Luo, X., Wang, Y., Xu, A., Hao, K., & Wang, Z. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s484327 · Cited by 10 · see citing works

Nanotoxicology: Towards Safety by Design

Andón, F. T., & Fadeel, B. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-08084-0_14 · Cited by 10 · see citing works

Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon

Pali‐Schöll, I., DeBoer, D. J., Alessandri, C., Seida, A. A., Mueller, R. S., & Jensen‐Jarolim, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01697 · Cited by 10 · see citing works

Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy

Diesner, S. C., Bergmayr, C., Wang, X.-Y., Heiden, D., Exenberger, S., Roth-Walter, F., Starkl, P., Ret, D., Pali-Schöll, I., Gabor, F., et al. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.03.017 · Cited by 9 · see citing works

The use of poly(D,L-lactic-co-glycolic) acid microspheres in the treatment of allergic disease

Reisacher, W. R., & Liotta, D. R. (2011) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e328345013a · Cited by 8 · see citing works

A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1

Castenmiller, C., Nagy, N. A., Kroon, P. Z., Auger, L., Desgagnés, R., Martel, C., Mirande, L., Morel, B., Roberge, J., Stordeur, V., et al. (2023) · World Allergy Organization Journal · doi:10.1016/j.waojou.2023.100839 · Cited by 7 · see citing works

Immune System

Boraschi, D., & Duschl, A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386940-1.00010-6 · Cited by 7 · see citing works

Effects of lipopolysaccharide-loaded PLGA nanoparticles in mice model of asthma by sublingual immunotherapy

Khakzad, M. R., Hajavi, J., Sadeghdoust, M., & Aligolighasemabadi, F. (2019) · International Journal of Polymeric Materials · doi:10.1080/00914037.2018.1561453 · Cited by 7 · see citing works

Immune System

Boraschi, D., Fadeel, B., & Duschl, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809199-9.00013-6 · Cited by 6 · see citing works

The Significance of Nanoparticles in Medicine and Their Potential Application in Asthma

Tortorella, S. M., & Karagiannis, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0706-9_10 · Cited by 6 · see citing works

Nanoparticles in Allergen‐Delivery Systems for Allergen‐Specific Immunotherapy

Lee, J. H., Chandrawati, R., & Lee, N. A. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400223 · Cited by 5 · see citing works

Asymmetric IgG Antibodies Induced by Different Immunotherapies in a Murine Model of Allergy

Apicella, C., Roldan, E. R., Chiappetta, D. A., Molinari, C., Bregni, C., Dokmetjian, J. C., & Gentile, T. (2009) · Immunological Investigations · doi:10.1080/08820130903005961 · Cited by 5 · see citing works

Desensitizing mice to ovalbumin through subcutaneous microsphere immunotherapy (SMITH)

Reisacher, W. R., Liotta, D. R., Yazdi, S., & Putnam, D. A. (2011) · International Forum of Allergy & Rhinology · doi:10.1002/alr.20074 · Cited by 4 · see citing works

Mannose targeting of poly(lactic-co-glycolic acid): a promising approach for improving sublingual allergen-specific immunotherapy

Haghnavaz, N., Rezaee, M. A., Pordel, S., Shobeiri, S. S., Dashti, M., Ansari, B., Khorrami, M., Moghadam, M., & Sankian, M. (2024) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2024.2410291 · Cited by 3 · see citing works

Vaccines as therapies for food allergies

Landers, J. J., & O’Konek, J. J. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.01.003 · Cited by 3 · see citing works

Evaluation of particulate systems supporting tumor cell fractions in a preventive vaccination against intracranial rat glioma

Sapin‐Minet, A., Clavreul, A., Garcion, E., Benoît, J., & Meneï, P. (2006) · Journal of neurosurgery · doi:10.3171/jns.2006.105.5.745 · Cited by 3 · see citing works

Nuevas formas farmacéuticas para el tratamiento de enfermedades alérgicas

Ferrer, M., Sanz, M. L., Gastaminza, G., del Pozo, V., de Souza, J., & Irache, J. M. (2012) · Anales del Sistema Sanitario de Navarra · doi:10.4321/s1137-66272012000100005 · Cited by 2 · see citing works

An Overview of Nanotechnological Approaches for the Diagnosis and Treatment of Allergic Illness

Sharma, B., & Deshmukh, R. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230828104015 · Cited by 2 · see citing works

The Hydrogel Based Allergen-Coated Gold Nanoparticles for Topical Administration: A Possible Epicutaneous Immunotherapy in Pollen-Sensitized Mice?

Pordel, S., Rezaee, M. A., Moghadam, M., & Sankian, M. (2024) · Immunological Investigations · doi:10.1080/08820139.2023.2298397 · Cited by 2 · see citing works

New advances in allergy immunotherapy

Reisacher, W. R., & Schwanke, T. W. (2016) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000255 · Cited by 2 · see citing works

Vaccines Against Non-Infectious, Non-Cancer Novel Targets

Garside, D. A., Acevedo, R., Alsaadi, M., Nimmo, N., Gebril, A., Lamprou, D. A., Mullen, A. B., & Ferro, V. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-416603-5.00010-9 · Cited by 1 · see citing works

Nanoparticles as Adjuvant-Vectors for Vaccination

Espuelas, S., Gamazo, C., Blanco‐Prieto, M. J., & Irache, J. M. (2007) · CRC Press eBooks · doi:10.1201/9781420008449.ch20 · Cited by 1 · see citing works

Shape variation in cranium, mandible and teeth in selected mouse strains

Ağaç, D. K., Oktay, E., Onuk, B., Kabak, M., & Gündemir, O. (2024) · Anatomia Histologia Embryologia · doi:10.1111/ahe.13064 · Cited by 1 · see citing works

Solid Lipid and Polymeric Nanoparticles for Drug Delivery

Pedraz, J. L., Orive, G., Igartúa, M., Rodríguez‐Gascón, A., Hernández, R. M., Solinís, M. Á., & Esquisabel, A. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0116 · Cited by 1 · see citing works

Nanotechnology and Food Allergy

Mills, E. N. C., Aleexev, Y., & Mackie, A. R. (2011) · Wiley eBooks · doi:10.1002/9783527634798.ch13 · Cited by 1 · see citing works

Novel allergen preparations for use in allergen-specific immunotherapy

Neimert-Andersson, T. (2008) · Figshare

The Effect Of The Physical Form Of Biodegradable Polymer Carriers On The Humoral Immune Response To Co-Delivered Antigen

Bennewitz, N. L. (2004) · UPT. Syiah Kuala University Library (Syiah Kuala University)

Therapeutic Immune Tolerance Approaches for the Treatment of Allergic Disease

Smarr, C. B., Getts, D. R., & Miller, S. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801577-3.00011-3

Original articles M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy

Roth‐Walter, F., Untersmayr, E., Fuchs, R., Boltz‐Nitulescu, G., Scheiner, O., Gabor, F., & Jensen‐Jarolim, E. (2004)

Applications of Nanomaterials for Activation and Suppression of Immune Responses

Shakya, A. K., & Nandakumar, K. S. (2014) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-4666-6363-3.ch011

PLGA microparticles for oral allergen immunotherapy

Ratzinger, G., Roth‐Walter, F., Untersmayr, E., Michael, Jensen‐Jarolim, E., & Gabor, F. (2007)

Expanding Allergen-specific Tr-1 CD4+ T cells to treat Allergic Asthma

Chakraborty, M. (2017) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26039

Applications of Nanomaterials for Activation and Suppression of Immune Responses

Shakya, A. K., & Nandakumar, K. S. (2017) · IGI Global eBooks · doi:10.4018/978-1-5225-1798-6.ch034

Innovative approaches to immunization

O’Konek, J. J., & Baker, J. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96018-2.00074-2

Biodegradable particles as vaccine delivery systems

Joshi, V. B., Salem, A. K., Donovan, M. D., Flanagan, D. R., Thorne, P. S., & Stevens, L. L. (2014) · doi:10.17077/etd.q3wwcov7

Biodegradable PLGA Particles for Improved Systemic and Mucosal Treatment of Type I Allergy

Schöll, I., Kopp, T., Bohle, B., & Jensen-Jarolim, E. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.02.007 · Cited by 40 · see citing works

Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma

Mei, L., Zeng, X., Liu, Z., Zhang, X., Ma, L., Xiao, X., Liu, X., & Yu, H. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51633 · Cited by 53 · see citing works

Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres

Jilek, S., Walter, E., Merkle, H. P., & Corthésy, B. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.05.065 · Cited by 39 · see citing works

Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization

Smarr, C. B., Yap, W. T., Neef, T., Pearson, R. M., Hunter, Z. N., Ifergan, I., Getts, D. R., Bryce, P. J., Shea, L. D., & Miller, S. D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505782113 · Cited by 94 · see citing works

The Use of Biodegradable Nanoparticles for Tolerogenic Therapy of Allergic Inflammation

Smarr, C. B., & Miller, S. D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7896-0_25 · Cited by 4 · see citing works